Medium-Term Outcomes of Conservative and Surgical Treatments for Stress Urinary Incontinence: A Medicare Claims Analysis: Developed by the AUGS Payment Reform Committee.

Evelyn F Hall, Daniel H Biller, Joanna L Buss, Tanaz Ferzandi, Gabriela E Halder, Tyler M Muffly, Katelin B Nickel, Mikio Nihira, Margaret A Olsen, Shannon L Wallace, Jerry L Lowder
Author Information
  1. Evelyn F Hall: From the Department of Obstetrics and Gynecology, Tufts University, Boston, MA.
  2. Daniel H Biller: Division of Urogynecology, Department of OBGYN, Vanderbilt University Medical College, Nashville, TN.
  3. Joanna L Buss: Institute for Informatics, Washington University School of Medicine, St Louis, MO.
  4. Tanaz Ferzandi: Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, Keck School of Medicine at University of Southern California, Los Angeles, CA.
  5. Gabriela E Halder: Division of Urogynecology, Department of OBGYN, University of Texas Medical Branch, Galveston, TX.
  6. Tyler M Muffly: Department of Obstetrics and Gynecology, Denver Health and Hospital Authority, Denver, CO.
  7. Katelin B Nickel: Division of Infectious Diseases, Department of Internal Medicine, Washington University in St Louis, St Louis, MO.
  8. Mikio Nihira: KPC Healthcare, UC Riverside School of Medicine, Riverside, CA.
  9. Margaret A Olsen: Division of Infectious Diseases, Department of Internal Medicine, Washington University in St Louis, St Louis, MO.
  10. Shannon L Wallace: Division of Urogynecology, Subspecialty Care for Women's Health, Cleveland Clinic, Cleveland, OH.
  11. Jerry L Lowder: Department of Obstetrics and Gynecology, Washington University in St Louis, St Louis, MO.

Abstract

OBJECTIVE: This study aimed to evaluate the 3- to 5-year retreatment outcomes for conservatively and surgically treated urinary incontinence (UI) in a population of women 66 years and older.
METHODS: This retrospective cohort study used 5% Medicare data to evaluate UI retreatment outcomes of women undergoing physical therapy (PT), pessary treatment, or sling surgery. The data set used inpatient, outpatient, and carrier claims from 2008 to 2016 in women 66 years and older with fee-for-service coverage. Treatment failure was defined as receiving another UI treatment (pessary, PT, sling, Burch urethropexy, or urethral bulking) or repeat sling. A secondary analysis was performed where additional treatment courses of PT or pessary were also considered a treatment failure. Survival analysis was used to evaluate the time from treatment initiation to retreatment.
RESULTS: Between 2008 and 2013, 13,417 women were included with an index UI treatment, and follow-up continued through 2016. In this cohort, 41.4% received pessary treatment, 31.8% received PT, and 26.8% underwent sling surgery. In the primary analysis, pessaries had the lowest treatment failure rate compared with PT (P<0.001) and sling surgery (P<0.001; survival probability, 0.94 [pessary], 0.90 [PT], 0.88 [sling]). In the analysis where retreatment with PT or a pessary was considered a failure, sling surgery had the lowest retreatment rate (survival probability, 0.58 [pessary], 0.81 [PT], 0.88 [sling]; P<0.001 for all comparisons).
CONCLUSIONS: In this administrative database analysis, there was a small but statistically significant difference in treatment failure among women undergoing sling surgery, PT, or pessary treatment, but pessary use was commonly associated with the need for repeat pessary fittings.

References

  1. Cochrane Database Syst Rev. 2018 Oct 04;10:CD005654 [PMID: 30288727]
  2. Obstet Gynecol. 2007 Aug;110(2 Pt 1):346-53 [PMID: 17666610]
  3. Health Care Financ Rev. 2008 Spring;29(3):27-42 [PMID: 18567241]
  4. Neurourol Urodyn. 2018 Sep;37(7):2271-2272 [PMID: 30106223]
  5. N Engl J Med. 2013 Sep 19;369(12):1124-33 [PMID: 24047061]
  6. JAMA. 2014 May 21;311(19):2007-14 [PMID: 24846038]
  7. J Clin Epidemiol. 2000 Dec;53(12):1258-67 [PMID: 11146273]
  8. Med Care. 2017 Dec;55(12):e170-e176 [PMID: 29135782]
  9. Obstet Gynecol. 2010 Mar;115(3):609-617 [PMID: 20177294]
  10. Curr Opin Obstet Gynecol. 2013 Oct;25(5):404-9 [PMID: 23872710]
  11. Med Care. 1998 Jan;36(1):8-27 [PMID: 9431328]
  12. Int J Womens Health. 2018 Apr 17;10:195-201 [PMID: 29713205]
  13. Cochrane Database Syst Rev. 2017 Jul 31;7:CD006375 [PMID: 28756647]
  14. Am J Obstet Gynecol. 2021 Aug;225(2):166.e1-166.e12 [PMID: 33727114]
  15. JAMA. 2017 Oct 24;318(16):1592-1604 [PMID: 29067433]
  16. Int Urogynecol J. 2018 Jan;29(1):109-118 [PMID: 28547268]
  17. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(5):326-9 [PMID: 12355294]
  18. Patient Educ Couns. 2015 Oct;98(10):1172-9 [PMID: 26215573]
  19. Cochrane Database Syst Rev. 2020 Jan 28;1:CD001754 [PMID: 31990055]

Grants

  1. K12 AR084228/NIAMS NIH HHS
  2. K12 HD052023/NICHD NIH HHS
  3. UL1 TR002345/NCATS NIH HHS

MeSH Term

Female
Aged
Humans
United States
Urinary Incontinence, Stress
Retrospective Studies
Suburethral Slings
Medicare
Urinary Incontinence

Word Cloud

Created with Highcharts 10.0.0treatmentpessaryPTsling0retreatmentwomensurgeryfailureanalysisUIevaluateusedP<0001studyoutcomes66yearsoldercohortMedicaredataundergoing20082016repeatconsideredreceived8%lowestratesurvivalprobability[pessary][PT]88[sling]OBJECTIVE:aimed3-5-yearconservativelysurgicallytreatedurinaryincontinencepopulationMETHODS:retrospective5%physicaltherapysetinpatientoutpatientcarrierclaimsfee-for-servicecoverageTreatmentdefinedreceivinganotherBurchurethropexyurethralbulkingsecondaryperformedadditionalcoursesalsoSurvivaltimeinitiationRESULTS:201313417includedindexfollow-upcontinued414%3126underwentprimarypessariescompared94905881comparisonsCONCLUSIONS:administrativedatabasesmallstatisticallysignificantdifferenceamongusecommonlyassociatedneedfittingsMedium-TermOutcomesConservativeSurgicalTreatmentsStressUrinaryIncontinence:ClaimsAnalysis:DevelopedAUGSPaymentReformCommittee

Similar Articles

Cited By